AeroVironment, Inc. (AVAV) — Q3 FY2026 Earnings Preview

1. Quarterly Performance Trend

Revenue stepped up dramatically following the BlueHalo acquisition (closed May 1, 2025). GAAP EPS is distorted by ~$75M/quarter in intangible amortization and purchase price allocation charges — adjusted EPS is the operative figure.

Key trend: Revenue has plateaued sequentially at ~$455–$475M across Q1–Q3 post-acquisition. Sequential growth of just +1.6–5.8% from Q2 to Q3 reflects the shutdown drag. The real test is Q4, where management guides ~$563–$590M in revenue and high-30s gross margins.

2. Full Year Estimates

FY2026 (ends April 30, 2026)

FY2027 Preliminary View

No formal FY2027 guidance has been issued. Management commentary suggests a strong setup: "set us up really well for fiscal year '27" (McDonnell, Q2 call). First formal FY2027 outlook is expected at Q4 earnings. Street consensus forward P/E of 57x implies the market is pricing meaningful earnings acceleration into FY2027. Key variables: SCAR recompete outcome, Salt Lake City factory ramp ($2B+ Switchblade capacity), funded task order conversion from $3.5B contract ceiling, and international FMS deliveries.

3. Consensus Expectations — Q3 FY2026

Management's Implied Q3 Targets

• Revenue: ~$460–$483M (45% of H2 = 45% × $1.02–$1.07B)
• EBITDA: ~$56–$63M (30% of H2 EBITDA; very low bar)
• Gross Margin: Should improve from Q2's 27% — management guided "improve in Q3 and be in the high-30s by Q4"
• SG&A: Targeting 12–13% of revenue by year-end (was 14% in Q2)

Options-Implied Move

The market is pricing a ~$36 move in either direction. The 2.1:1 call/put ratio and 0.71 put/call OI suggest modestly bullish positioning heading into the print. Last quarter saw a 12.85% selloff on a miss — the implied 16% move captures that tail risk with room for a larger reaction given SCAR uncertainty.

4. Analyst Views Prior to Earnings

Coverage Snapshot: 20 Analysts

Post-SCAR Price Target Revisions (March 2–10, 2026)

Bull Case

• SCAR is re-winnable: BlueHalo has technical incumbency and AVAV management says it is "confident in its position despite recompete." Active talks with Space Force on contract terms.
• Organic momentum strong: Legacy AV revenue grew +21% YoY organically in Q2. Switchblade/P550/LOCUST demand is secular, not cyclical.
• Valuation compressed: Stock at $226 vs. median PT ~$330. If SCAR resolves favorably, re-rating to mid-$300s is straightforward math.
• Pipeline massive: $3.5B in contract ceiling awards, $874M FMS IDIQ, Golden Dome optionality. Management sees "precipice of significant growth."
• ARK adding: Cathie Wood increased stake by 29% — high-profile growth conviction signal.

Bear Case

• SCAR loss would gut the thesis: ~50% of backlog at risk per Raymond James. If lost, BlueHalo's $4.1B acquisition premium comes under fundamental question.
• Margin trajectory unproven: Q2 was 27% adj gross margin. Management has promised improvement but not delivered yet. Margins need to move NOW.
• Valuation still rich: Even at $226, forward P/E is ~57x vs. defense peers at 15–25x. Premium requires both growth + margin inflection.
• Government shutdown killed Q3 bookings: Funded backlog was flat at $1.1B in Q2 despite record awards. May stay flat again.
• CFO transition risk: Kevin McDonnell's retirement during the most complex integration in company history adds execution risk.

5. Strategic News Flow (Last 120 Days)

Contract Awards

• Dec 8, 2025: $874M sole-source IDIQ from U.S. Army for international UAS/C-UAS systems to allied forces (five-year vehicle)
• Oct 1, 2025: $499M AFRL contract — 10-year IDIQ for electromagnetic spectrum survivable materials ($246M in task orders at announcement)
• Q2 FY2026: $3.5B in total contract ceiling awards (record) including BADGER phased array, HMIF, and laser comms
• Feb 26, 2026 (post-Q3): $186M U.S. Army order — Switchblade 600 Block 2 and Switchblade 300 Block 20 with EFP payloads under $990M LUS contract
• Mar 5, 2026 (post-Q3): $97.4M Army contract — three-year advanced testing environment development

SCAR Recompete — The Headline Risk

• January 2026: Space Force issued stop-work order on BADGER satellite antenna deliveries under the $1.4B SCAR program
• ~March 2, 2026: Space Force officially reopened bidding on the full SCAR contract. Pentagon cited supply chain concerns and shift toward firm-fixed-price contracting
• March 2: Raymond James triple-downgraded AVAV (Strong Buy → Underperform), calling SCAR ~50% of total backlog. Stock crashed ~20% from prior close
• March 4–5: AVAV management in active talks with Space Force on contract terms. Company stated it is "confident in its position despite recompete" (Aviation Week)
• SCAR was a BlueHalo crown jewel — BADGER phased array antennas for satellite ground stations. A loss would challenge the acquisition rationale

Government Shutdown / Funding Timeline

• Oct 1, 2025: Government shutdown began (FY2026 start)
• Nov 12, 2025: Shutdown ended; CR extended funding through Jan 30, 2026
• Late Jan 2026: Brief second shutdown (4 days) due to House delays
• Feb 3, 2026: House passed $839B defense spending bill — full FY2026 Pentagon appropriations
• Impact: AVAV Q3 (Nov 1 – Jan 31) was almost entirely under CR, limiting new contract starts and delaying procurement decisions. Full appropriations passed AFTER Q3 ended.

Geopolitical

• Feb 28, 2026: "Operation Epic Fury" — U.S.-Israel strikes on Iranian infrastructure. AVAV surged 20%+ intraday before SCAR reversal
• Ongoing: Ukraine production agreement for localized Switchblade 600 manufacturing. Ukraine revenue de-risked to <5% of FY2026
• International MOUs: Taiwan NCSIST, Korean Air, Dutch MoD fleet expansion, Denmark UAS training

6. Analyst Questions & Concerns from Q2 FY2026 Earnings Call

Fourteen analysts participated in Q2 Q&A (Dec 9, 2025). The dominant themes reveal what the Street will be re-testing on the Q3 call:

Theme 1: Bookings Conversion & Funded Backlog

• Goldman Sachs (Valentini): Pressed on catalyst path for growth — funded backlog was flat at $1.1B despite $1.4B in bookings and $3.5B in contract ceiling awards. "The question everyone's asking is: when does this convert?"
• Stifel (Siegmann): Specifically asked about shutdown friction on Q3 bookings
• Management response: Funding was delayed, not lost. "We expect a significant number of additional funded task orders in Q3 and Q4."

Theme 2: Margin Trajectory

• Jefferies (Konrad): BADGER/SCAR production ramp and margin impact
• RBC (Strackhouse): SCDE segment margin trajectory — specifically asked about timeline to breakeven
• Cantor (Canfield): EBITDA bridge to Q4, SG&A leverage
• Management response: Q2 was margin trough (27% adj gross). "Should improve in Q3 and be in the high-30s by Q4." SCDE margins improving as contracts migrate from cost-plus to firm-fixed-price.

Theme 3: Product Catalysts

• BofA (Stiroh): Product-level growth, Switchblade specifically
• BTIG (Madrid): $900M international IDIQ, C-UAS export, Red Dragon vs. SB600
• William Blair (DiPalma): Laser comms contract upsized to $381M (with options)
• Alembic (Skibitski): P550/LRR competitive dynamics and export potential

Theme 4: Cash Flow & Working Capital

• Baird (Arment): Unbilled receivables elevated — when do they normalize?
• Cantor (Canfield): Free cash flow bridge, working capital trajectory
• Management response: 50% cash conversion to EBITDA target for FY2026. H2 improvement expected. Unbilled receivables "at a higher level than we are targeting."

Theme 5: International & Policy

• Piper Sandler (Jeffries): MTCR/UAS policy changes and international impact
• Canaccord (Moeller): Ukraine backlog and European demand
• Needham (Bohlig): OBB funding baked into guidance

7. What to Listen For Tonight

• 1. SCAR Recompete Update: This is the call. What is the timeline? Is AVAV rebidding? What's the backlog impact? Has the stop-work been lifted or extended? Management's tone and specificity here will determine post-earnings direction. Anything beyond "we're confident" — timeline, partial resolution, re-win framework — would be very constructive.
• 2. Funded Backlog: Was flat at $1.1B in Q2 despite record awards because the shutdown prevented funding. Did OBB money flow in January? An increase to $1.3B+ would signal the conversion thesis is intact. Flat or declining would be a red flag — especially combined with SCAR uncertainty.
• 3. Margin Inflection: Q2 was 27% adj gross margin (trough). Management guided "improve in Q3, high-30s by Q4." Delivery of 30%+ in Q3 would validate the trajectory. Sub-28% would break the narrative. Watch for commentary on cost-plus to FFP contract migration and Oracle ERP normalization.
• 4. FY2026 Guidance Update: With one quarter remaining and 93% visibility last quarter, expect narrowing. A raise would be bullish (signals Q4 confidence). Maintained guidance is neutral. A cut — even small — would be devastating given SCAR overhang.
• 5. P550 / Switchblade Orders: Management was explicit that "significant orders" for P550 were expected in Q3/Q4. Confirmation of Army LRR task orders would validate the largest near-term organic growth catalyst. The $186M Switchblade order announced Feb 26 (post-Q3) signals pipeline strength but was NOT in Q3 numbers.

Secondary Items

• FY2027 Framing: First formal outlook likely at Q4, but directional commentary tonight matters. McDonnell called FY2027 setup "really strong" — does that still hold post-SCAR?
• Cash Flow / Working Capital: 50% EBITDA-to-cash conversion target. Unbilled receivables should start declining. Watch for specific Q3 free cash flow number.
• International Pipeline: Any FMS shipments during Q3? New country wins? FMS process was disrupted by the shutdown.
• CFO Transition Details: McDonnell retirement timing and successor announcement.
• Golden Dome Positioning: Any new awards or discussions? OMB funding delays could impact near-term.

8. Management Guidance (Last 120 Days)

FY2026 Guidance Evolution

H2 Split Guidance

• Revenue: ~45% Q3 / ~55% Q4 → implies Q3 ~$460–$483M, Q4 ~$563–$590M
• EBITDA: ~30% Q3 / ~70% Q4 → implies Q3 ~$56–$63M, Q4 ~$132–$146M
• Gross Margin: Improve in Q3 from Q2's 27%, reach high-30s by Q4, full-year in the low-30s
• SG&A: Target 12–13% of revenue by year-end (was 14% in Q2)
• R&D: 6–7% of revenue for full year

Management Tone Shift: Q1 → Q2

Q1 (Sep 9): Exuberant. CEO Nawabi: "We're going to be the poster child of what a defense tech company in the front should look like." CFO McDonnell predicted Q2 bookings "could be well over $1 billion, approaching $2 billion."

Q2 (Dec 9): Confident but grounded. Nawabi: "Despite the challenges posed by the elongated US government shutdown, we delivered excellent financial results." On guidance: "The reason why we hesitated to raise the guidance even more is because there is still some timing risk on when we are going to get some of these task orders." McDonnell: "We think we're on the precipice of some significant growth across all those categories."

"It is really hard to predict exactly how much. There is a lot of demand coming our way, and we're getting ready for it." — Wahid Nawabi, CEO, Q2 FY2026 Call

9. Catalysts to Watch — Next 90 Days

10. Key Risks & Considerations

SCAR Recompete HIGH

The single largest risk to the investment thesis. The $1.4B Space Force SCAR program — a BlueHalo crown jewel — has been reopened for competitive bidding with a stop-work order already in effect. Raymond James estimates SCAR represents ~50% of total backlog. If lost entirely, the $4.1B BlueHalo acquisition premium comes under fundamental question. Even a re-win under firm-fixed-price terms (vs. prior cost-plus) would compress margins. The Pentagon's broader shift away from cost-plus contracting is a structural headwind for BlueHalo's legacy service business. Large primes (Northrop Grumman, L3Harris, Lockheed Martin) are expected to bid aggressively.

Margin Execution HIGH

Adjusted gross margin compressed from legacy ~41–45% to 27% post-BlueHalo due to higher service mix (75% over-time revenue vs. 41% pre-deal), early-stage product maturation, Oracle ERP transition costs, and unfavorable shutdown-driven product mix. Management has promised sequential improvement but has not yet delivered a quarter above 29% post-acquisition. Failure to show margin inflection in Q3 would break the narrative that H2 FY2026 is the turning point.

Government Shutdown / Funding Delays MEDIUM

Q3 FY2026 almost entirely overlapped with continuing resolution or shutdown conditions. Full defense appropriations only passed February 3, 2026 — after Q3 ended. This likely delayed new contract starts, procurement decisions, and funded task orders. Management explicitly warned: "With the government shutdown impacting both our fiscal Q2 and Q3, we have seen delays in some of the orders." Funded backlog may remain flat.

Valuation Premium MEDIUM

At $226, AVAV trades at ~57x forward adjusted P/E vs. defense peer group at 15–25x and Kratos (KTOS) at ~118x. The premium requires simultaneous delivery of organic growth acceleration, margin expansion, and BlueHalo synergy realization. A miss on any dimension — particularly combined with SCAR uncertainty — risks a meaningful de-rating. The wide analyst PT range ($259–$450) itself signals deep disagreement on fair value.

CFO Transition MEDIUM

Kevin McDonnell's announced retirement comes during the most complex operational period in AVAV's history: BlueHalo integration, Oracle ERP migration, new segment reporting, and the SCAR recompete. Successor timing and quality will matter.

Unbilled Receivables / Cash Conversion MEDIUM

Over-time revenue recognition jumped from 41% to 75% of total revenue post-BlueHalo, structurally elevating unbilled receivables. Management has flagged these are "at a higher level than we are targeting." The 50% EBITDA-to-cash conversion target for FY2026 requires significant H2 improvement in working capital. Failure to show progress would raise questions about earnings quality.

Competition & Market Structure LOW-MED

Pentagon's multi-vendor preference and FFP push reduces single-source advantages. In small UAS/loitering munitions, AVAV remains the pure-play leader, but private competitors (Shield AI, Anduril) are growing rapidly in adjacent autonomous systems. Large primes are increasingly competing for attritable drone contracts. The SCAR recompete itself opens the door for direct competition on what was a sole-source program.